MUTIERTE IMMUNGLOBULINBINDENDE POLYPEPTIDE
European patent · EP3455244 · In force
Register entry
- Publication number
- EP3455244
- Application number
- EP17728070
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 10, 2017
- Published
- Mar 20, 2019
- Granted
- May 4, 2022
- Protection ends at the latest
- May 9, 2037
- Next annual fee due
- May 31, 2027
- IPC classes
- C07K 14/31 (2006.01)G01N 33/68 (2006.01)
- Priority
- GB 201608229 11.05.2016GB 201608232 11.05.2016US 201615282367 30.09.2016
- PCT application
- PCT/EP2017/061162 10.05.2017
- PCT publication
- WO2017/194596 16.11.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 1, 2023
Change
Published in Swissreg on 01.06.2023
- May 9, 2023
Address changed
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 09.05.2023
- Mar 15, 2023
Change
Published in Swissreg on 15.03.2023
- May 10, 2022
Agent entered
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel
Published in Swissreg on 10.05.2022
- May 4, 2022
Granted
Published in Swissreg on 04.05.2022
Parties
Inventor
751 84 Uppsala, SE
751 84 Uppsala, SE
751 84 Uppsala, SE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.